Peter Kolchinsky's Net Worth
Estimate Recalculated Dec 3, 2025 07:31PM EST
Who is Peter Kolchinsky
Peter Kolchinsky does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., Dicerna Pharmaceuticals Inc, Eidos Therapeutics, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., PMV Pharmaceuticals, Inc., Nkarta, Inc., DICE Therapeutics, Inc., SANGAMO BIOSCIENCES INC, Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., Inhibrx, Inc., RxSight, Inc., Phathom Pharmaceuticals, Inc., Dyne Therapeutics, Inc., TG THERAPEUTICS, INC., Aclaris Therapeutics, Inc., Eiger BioPharmaceuticals, Inc., Eliem Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Research Alliance Corp. II, Forma Therapeutics Holdings, Inc.,, Therapeutics Acquisition Corp., G1 Therapeutics, Inc., ARVINAS INC., Synthorx, Inc., CURIS INC, Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Inozyme Pharma, Inc., Pandion Therapeutics Holdco LLC, Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, scPharmaceuticals Inc., Satsuma Pharmaceuticals, Inc., Akouos, Inc., Cardiff Oncology, Inc., Wave Life Sciences Ltd., Werewolf Therapeutics, Inc., IMARA Inc., Ra Pharmaceuticals, Inc., Fulcrum Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, ARS Pharmaceuticals, Inc., PepGen Inc., Black Diamond Therapeutics, Inc., DERMA SCIENCES, INC., SEQUENOM INC, BIOSPECIFICS TECHNOLOGIES CORP, Acrivon Therapeutics, Inc., ARADIGM CORP, LIPID SCIENCES INC/, LENZ Therapeutics, Inc., Boundless Bio, Inc., Cidara Therapeutics, Inc., and Artiva Biotherapeutics, Inc..
SEC CIK
Peter Kolchinsky's CIK is 0001384859
Past Insider Trading and Trends
2018 was Peter Kolchinsky's most active year for acquiring shares with 3 total transactions. Peter Kolchinsky's most active month to acquire stocks was the month of May. 2020 was Peter Kolchinsky's most active year for disposing of shares, totalling 2 transactions. Peter Kolchinsky's most active month to dispose stocks was the month of December. 2018 saw Peter Kolchinsky paying a total of $0.00 for 64,000 shares, this is the most they've acquired in one year. In 2020 Peter Kolchinsky cashed out on 45,335 shares for a total of $2,562,626.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
